Steven Ayers, DO
Psychiatry · Hilo, HINPI 1225425754
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $325 and has fallen 94.3% since, to $19 in 2025.
Across 44 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$107
- Corium, LLC$97
- AbbVie$89
- Tris Pharma Inc$82
- Takeda Pharmaceuticals U.S.A., Inc.$70
- Johnson & Johnson$57
- plus $217 from 8 others
What the payments were for
- Food & beverage$720100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$720 in reported general payments places this provider in the 70th percentile of 183 psychiatry providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 44 | $1,481 |
| Divalproex Sodium ErDivalproex Sodium | 11 | $909 |
| Duloxetine Hcl | 22 | $766 |
| Lamotrigine | 44 | $611 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $573 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 25 | $512 |
| Bupropion Hcl SrBupropion Hcl | 22 | $431 |
| Gabapentin | 17 | $412 |
| Quetiapine Fumarate | 24 | $356 |
| Fluoxetine Hcl | 20 | $256 |
| Sertraline Hcl | 18 | $220 |
| Trazodone Hcl | 23 | $189 |
| Diazepam | 12 | $179 |
| Amitriptyline Hcl | 15 | $158 |
| Aripiprazole | 11 | $134 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Hilo
- Vanessa EaglinHilo$2K
- John HeasterHilo$2K
- Dennis LeeHilo$1K
- Ulziibat PersonHilo$1K
- Denis Mee-LeeHonolulu$526K
- David SteinHonolulu$186K
- Michael ZafraniAiea$29K
- Jon CooneyAiea$21K
- Harry ChingonAiea$15K
- Edward WuKaneohe$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.